Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

January 28, 2024

Study Completion Date

February 28, 2025

Conditions
Mitral Valve Prolapse
Interventions
OTHER

Focus Groups/Quantitative Survey for Patients

5 quantitative focus groups will be conducted with 5-10 patients each to elicit the range of outcomes patients consider important when selecting treatment options. 100 quantitative surveys to characterize how patients with severe MR prioritize outcomes when making treatment decisions.

OTHER

Focus Group/Quantitative Survey for HCPs

5 quantitative focus groups will be conducted with 5-10 providers to elicit the range of outcomes providers consider important when recommending treatment options to patients. 100 quantitative surveys to characterize how providers prioritize outcomes for patients with severe MR when making treatment recommendations.

OTHER

Qualitative Focus Group

Qualitative focus groups will be conducted to determine barriers and facilitators to implementing shared decision making in multidisciplinary mitral valve heart team clinics.

Trial Locations (5)

10075

RECRUITING

Northwell Health, New York

26506

RECRUITING

West Virginia University Medicine, Morgantown

44195

RECRUITING

Cleveland Clinic, Cleveland

64111

RECRUITING

Saint Luke's Hospital, Kansas City

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

West Virginia University

OTHER

collaborator

Cedars-Sinai Medical Center

OTHER

collaborator

The Cleveland Clinic

OTHER

collaborator

University of Kansas Medical Center

OTHER

collaborator

Saint Luke's Mid America Heart Institute

UNKNOWN

lead

Northwell Health

OTHER

NCT06738537 - Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse | Biotech Hunter | Biotech Hunter